Lidokain/Adrenalin Aguettant

Lidocaine hydrochloride, the active ingredient in Lidokain/Adrenalin Aguettant, is a local anesthetic presented as a sterile solution for injection use. It provides local anesthesia for surgical or diagnostic procedures in adult patients. Epinephrine is included to prolong the anesthetic effect and reduce systemic absorption.

GNH USA supplies Lidokain/Adrenalin Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lidokain/Adrenalin Aguettant is a local anesthetic combination used in procedures requiring regional or infiltration anesthesia.

- Surgical procedures: provides rapid onset local anesthesia with prolonged duration for incision and excision. - Epidural analgesia: enables effective pain control during labor, obstetric or postoperative management. - Intravenous regional anesthesia (Bier block): allows safe, reversible anesthesia of a limb for short surgical interventions.

Lidokain/Adrenalin Aguettant may cause a range of adverse reactions.

Common Side Effects: - Transient pain or burning at the injection site. - Tachycardia or increased heart rate. - Elevated blood pressure (hypertension). - Nausea or mild dizziness. - Localized swelling or erythema.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with airway compromise. - Cardiac arrhythmias, including ventricular tachycardia. - Seizures or central nervous system toxicity. - Methemoglobinemia. - Prolonged numbness or motor block beyond expected duration.

Before using Lidokain/Adrenalin Aguettant, consider the following safety measures.

- Assess cardiovascular status: evaluate heart rate and blood pressure prior to administration. - Avoid in patients with known hypersensitivity to lidocaine or epinephrine: discontinue use if reaction occurs. - Use caution in hyperthyroid patients: monitor for tachyarrhythmia. - Limit total dose: adhere to recommended maximum dose based on patient weight and procedure. - Store at room temperature: keep in original container, protect from light and moisture.

Lidokain/Adrenalin Aguettant can interact with several drug classes.

Major Interactions (Avoid): - Beta‑blockers: may potentiate bradycardia and hypotension. - Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis. - Tricyclic antidepressants: may enhance cardiotoxic effects of lidocaine.

Moderate Interactions (Monitor Closely): - Other local anesthetics: risk of cumulative systemic toxicity. - Diuretics: may raise plasma lidocaine concentrations. - CYP3A4 inhibitors: may modestly increase lidocaine levels.